For instance, TET1 and TET3 play a positive role in maintaining breast tumor-initiating cell phenotypes through the TET-TNFα-p38-MAPK axis, as evidenced by the CD44+/CD24− expression, a recognized biomarker of breast cancer stem cells [38]. This evidence concerns the gene TET3 and breast carcinoma.